Catalyst Category

FDA Approval

Live feed of every FDA Approval catalyst in Regulatory and Clinical.

CATALYSTS IN FEED

167

AVG MAX MOVE

+101.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

Regulatory and ClinicalFDA ApprovalOct 7, 2026 · 6:29am ET

LPCNLipocine Inc.

Lipocine Inc. Receives Health Canada Approval for TLANDO®

Approval for testosterone replacement therapy.

Regulatory and ClinicalFDA ApprovalOct 7, 2026 · 6:29am ET

LPCNLipocine Inc.+84.7%

Lipocine Inc. Receives Health Canada Approval for TLANDO®

Regulatory and ClinicalFDA ApprovalOct 5, 2026 · 8:46am ET

EDVAEndovia Health Sciences, Inc.

FDA Determines CannEpil® for Canine Bone Cancer Pain Qualifies as Minor Use

Endovia Health Sciences and Lupvindol BioSciences' product now eligible for Conditional Approval Pathway

Regulatory and ClinicalFDA ApprovalOct 5, 2026 · 8:46am ET

EDVAEndovia Health Sciences, Inc.+31.1%

FDA Determines CannEpil® for Canine Bone Cancer Pain Qualifies as Minor Use

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Loading…

FDA Approval

Lipocine Inc. Receives Health Canada Approval for TLANDO®

Lipocine Inc. Receives Health Canada Approval for TLANDO®

FDA Determines CannEpil® for Canine Bone Cancer Pain Qualifies as Minor Use

FDA Determines CannEpil® for Canine Bone Cancer Pain Qualifies as Minor Use

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

FDA Approval

Lipocine Inc. Receives Health Canada Approval for TLANDO®

Lipocine Inc. Receives Health Canada Approval for TLANDO®

FDA Determines CannEpil® for Canine Bone Cancer Pain Qualifies as Minor Use

FDA Determines CannEpil® for Canine Bone Cancer Pain Qualifies as Minor Use

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.